Africa Biosimilars Market (2024-2030) | Trends, Growth, Share, Value, Outlook, Forecast, Revenue, Size, Analysis, Industry & Companies

Market Forecast by Countries (South Africa, Nigeria, Kenya, Rest of Africa), By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC077222 Publication Date: Aug 2021 Updated Date: Jan 2024 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 200 No. of Figures: 90 No. of Tables: 30

Key Highlights of the Report:

  • Africa Biosimilars Market Outlook
  • Market Size of Africa Biosimilars Market, 2020
  • Forecast of Africa Biosimilars Market, 2030
  • Historical Data and Forecast of Africa Biosimilars Revenues & Volume for the Period 2020 - 2030
  • Africa Biosimilars Market Trend Evolution
  • Africa Biosimilars Market Drivers and Challenges
  • Africa Biosimilars Price Trends
  • Africa Biosimilars Porter's Five Forces
  • Africa Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Africa Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of South Africa Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Nigeria Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Kenya Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Africa Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Africa Biosimilars Market - Key Performance Indicators
  • Africa Biosimilars Market - Import Export Trade Statistics
  • Africa Biosimilars Market - Opportunity Assessment By Countries
  • Africa Biosimilars Market - Opportunity Assessment By Product
  • Africa Biosimilars Market - Opportunity Assessment By Indication
  • Africa Biosimilars Market - Opportunity Assessment By Manufacturing
  • Africa Biosimilars Market - Top Companies Market Share
  • Africa Biosimilars Market - Top Companies Profiles
  • Africa Biosimilars Market - Comparison of Players in Technical and Operating Parameters
  • Africa Biosimilars Market - Strategic Recommendations
  • Markets Covered
  • Africa Biosimilars Market report provides a detailed analysis of the following market segments:
  • By Product :
  • Insulin
  • Follitropin
  • Calcitonin
  • Glucagon
  • Teriparatide
  • Others
  • By Indication :
  • Oncology
  • Offsite Treatment
  • Chronic Disorders
  • Blood Disorders
  • Infectious Diseases
  • Others
  • By Manufacturing :
  • Outsourced
  • In-house
Frequently Asked Questions About the Market Study (FAQs):
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Africa Biosimilars Market Overview

3.1 Africa Regional Macro Economic Indicators

3.2 Africa Biosimilars Market Revenues & Volume, 2020 & 2030F

3.3 Africa Biosimilars Market - Industry Life Cycle

3.4 Africa Biosimilars Market - Porter's Five Forces

3.5 Africa Biosimilars Market Revenues & Volume Share, By Countries, 2020 & 2030F

3.6 Africa Biosimilars Market Revenues & Volume Share, By Form, 2020 & 2030F

3.7 Africa Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.8 Africa Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2030F

4 Africa Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Africa Biosimilars Market Trends

6 Africa Biosimilars Market, 2020 - 2030

6.1 Africa Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

6.2 Africa Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

6.3 Africa Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

7 South Africa Biosimilars Market, 2020 - 2030

7.1 South Africa Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

7.2 South Africa Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

7.3 South Africa Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

8 Nigeria Biosimilars Market, 2020 - 2030

8.1 Nigeria Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

8.2 Nigeria Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

8.3 Nigeria Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

9 Kenya Biosimilars Market, 2020 - 2030

9.1 Kenya Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

9.2 Kenya Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

9.3 Kenya Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

10 Rest of Africa Biosimilars Market, 2020 - 2030

10.1 Rest of Africa Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

10.2 Rest of Africa Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

10.3 Rest of Africa Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

11 Africa Biosimilars Market Key Performance Indicators

12 Africa Biosimilars Market - Opportunity Assessment

12.1 Africa Biosimilars Market Opportunity Assessment, By Countries, 2020 & 2030F

12.2 Africa Biosimilars Market Opportunity Assessment, By Product, 2020 & 2030F

12.3 Africa Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2030F

12.4 Africa Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2030F

13 Africa Biosimilars Market - Competitive Landscape

13.1 Africa Biosimilars Market Revenue Share, By Companies, 2020

13.2 Africa Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

14 Company Profiles

15 Recommendations

16 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All